Physician profile
Prashanth Iyer
NPI 1760879134
$3,640.67
in general payments reported to CMS, 2019-2025
13 companies · $318 in 2025
The $318 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $336 · 2021: $122 · 2022: $966 · 2023: $1,415 · 2024: $362 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,094.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $660.54 | 2022-2024 | Vabysmo |
| Regeneron Healthcare Solutions, INC. | $556.77 | 2019-2023 | Eylea Hd |
| Alcon Vision LLC | $390.81 | 2023 | Ngenuity, Constellation |
| Apellis Pharmaceuticals, INC. | $352.64 | 2022-2025 | Syfovre |
| Bausch & Lomb Americas INC. | $283.60 | 2022-2025 | Stellaris, Stellaris, Stellaris Elite |
| Regeneron Pharmaceuticals, INC. | $265.26 | 2023 | Eylea Hd |
| Abbvie INC. | $241.98 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $214.42 | 2020 | |
| Eyepoint US, INC. | $175.58 | 2022 | |
| Beaver-Visitec International, INC. | $144.09 | 2022 | |
| Alimera Sciences, INC. | $135.36 | 2022-2023 | Iluvien |
| Astellas Pharma US INC | $121.77 | 2023 | Izervay |
| Tarsus Pharmaceuticals, INC. | $97.85 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prashanth Iyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.